Marc and Stuart's Top Picks

We have condensed all our best ideas from across the Stocks Down Under coverage universe into Marc & Stuart's Top Picks.

These Top Picks are the best the ASX has to offer, in our our view, and we have selected them based on a combination of fundamental and technical analysis.

Through our email and SMS service we will let you know when to buy and, equally important, when to sell.

Investing has never been easier!
Marc & Stuart's Top Picks

General Advice Warning & Disclosures

Stocks Down Under provides General Advice only. Marc & Stuart's Top Picks cannot be taken as Personal Advice.

Marc & Stuart own shares in RMY, A2M, WBT, CYC, SE1, KNO, DCL, MEB, NOR, OBM, BEM, BKT, MP1 and FAR.

AVERAGE PERFORMANCE OF PAST TOP PICKS: 38.8%
Performance of past Top Picks
COMPANY NAME
ASX CODE
INCLUSION DATE
INCLUSION PRICE
EXCLUSION DATE
EXCLUSION PRICE
PERFORMANCE

  • 4DS Memory

    4DS
    December 8, 2021
    $0.051
    April 28, 2022
    $0.115
    125.49%

    4DS Memory
    ASX: 4DS

     

    Date of inclusion: 8 December 2021
    Share price on inclusion in Marc & Stuart’s Top Picks: $0.051

    Date of exclusion: 28 April 2022
    Share price on exclusion: $0.115

     

    Performance since inclusion: 125%

     

    Reason for exclusion: Strong resistance at 13 cents

     

    4DS Memory is back on track
    4DS Memory (ASX:4DS) recently announced it is back on track with the development of its ReRAM technology following major issues late in 2021...

    Save $$$
    Most Popular
    30-Day Free Trial
    $0
    No Credit Card Required!
    Get access to 4 publications
    Weekly Investor Webinar
    Access to Marc & Stuart's Top Picks
    Select
    Most Popular
    Profit Premium
    $69
    Get access to 4 publications
    Access to the full research Archive
    Weekly Investor Webinar
    Access to Marc & Stuart's Top Picks
    Select
    Most Popular
    30-Day Free Trial
    $0
    No Credit Card Required!
    Get access to 4 publications
    Weekly Investor Webinar
    Access to Marc & Stuart's Top Picks
    Select
    Most Popular
    Profit Premium
    $59
    BILLED ANNUALLY
    Get access to 4 publications
    Access to the full research Archive
    Weekly Investor Webinar
    Access to Marc & Stuart's Top Picks
    Select
    4DS, 4DS Memory, past-pick

  • Appen

    APX
    March 17, 2021
    $18.11
    May 6, 2021
    $11.63
    -35.78%

    Date of inclusion: 17 March 2021
    Share price on inclusion: $18.11

    Date of exclusion: 6 May 2021
    Share price on exclusion: $11.63

     

    Reason for exclusion: CEO is flagging increasing competition

    Surprising that management would mention this at a conference
    On Thursday morning, 6 May at the Macquarie Australia Conference, CEO Mark Brayan flagged that Appen is experiencing increasing competition from smaller competitors that are increasingly well-funded. He called it “maturing com...

    Save $$$
    Most Popular
    30-Day Free Trial
    $0
    No Credit Card Required!
    Get access to 4 publications
    Weekly Investor Webinar
    Access to Marc & Stuart's Top Picks
    Select
    Most Popular
    Profit Premium
    $69
    Get access to 4 publications
    Access to the full research Archive
    Weekly Investor Webinar
    Access to Marc & Stuart's Top Picks
    Select
    Most Popular
    30-Day Free Trial
    $0
    No Credit Card Required!
    Get access to 4 publications
    Weekly Investor Webinar
    Access to Marc & Stuart's Top Picks
    Select
    Most Popular
    Profit Premium
    $59
    BILLED ANNUALLY
    Get access to 4 publications
    Access to the full research Archive
    Weekly Investor Webinar
    Access to Marc & Stuart's Top Picks
    Select
    Appen, APX, past-pick

  • Baby Bunting

    BBN
    March 10, 2021
    $5.04
    April 8, 2021
    $5.93
    17.66%

    Date of inclusion: 10 March 2021
    Share price on inclusion: $5.04

    Date of exclusion: 8 April 2021
    Share price on exclusion: $5.93

     

    Following 17.7% performance since inclusion in Marc & Stuart's Top Picks, we sold Baby Bunting (ASX:BBN). While there's nothing wrong with the company from a fundamental point of view, at April 8th close of $5.93 we believe the stock has run into a very strong resistance level between $5.95 and $6.00. There is downside risk and we expect the stock...

    Save $$$
    Most Popular
    30-Day Free Trial
    $0
    No Credit Card Required!
    Get access to 4 publications
    Weekly Investor Webinar
    Access to Marc & Stuart's Top Picks
    Select
    Most Popular
    Profit Premium
    $69
    Get access to 4 publications
    Access to the full research Archive
    Weekly Investor Webinar
    Access to Marc & Stuart's Top Picks
    Select
    Most Popular
    30-Day Free Trial
    $0
    No Credit Card Required!
    Get access to 4 publications
    Weekly Investor Webinar
    Access to Marc & Stuart's Top Picks
    Select
    Most Popular
    Profit Premium
    $59
    BILLED ANNUALLY
    Get access to 4 publications
    Access to the full research Archive
    Weekly Investor Webinar
    Access to Marc & Stuart's Top Picks
    Select
    Baby Bunting, BBN, past-pick

  • Greenland Minerals

    GGG
    March 10, 2021
    $0.155
    April 22, 2021
    $0.077
    -50.32%

    Date of inclusion: 10 March 2021
    Share price on inclusion: $0.155

    Date of exclusion: 22 April 2021
    Share price on exclusion: $0.077

     

    We are removing Greenland Minerals from Marc and Stuart's Top Pick list. The 6 April 2021 election in Greenland resulted in a left wing government where the leading party in the new governing coalition campaigned against development of Greenland Minerals's Kvanefjeld Rare Earths Mine. The outgoing government had been in favour. With the new governm...

    Save $$$
    Most Popular
    30-Day Free Trial
    $0
    No Credit Card Required!
    Get access to 4 publications
    Weekly Investor Webinar
    Access to Marc & Stuart's Top Picks
    Select
    Most Popular
    Profit Premium
    $69
    Get access to 4 publications
    Access to the full research Archive
    Weekly Investor Webinar
    Access to Marc & Stuart's Top Picks
    Select
    Most Popular
    30-Day Free Trial
    $0
    No Credit Card Required!
    Get access to 4 publications
    Weekly Investor Webinar
    Access to Marc & Stuart's Top Picks
    Select
    Most Popular
    Profit Premium
    $59
    BILLED ANNUALLY
    Get access to 4 publications
    Access to the full research Archive
    Weekly Investor Webinar
    Access to Marc & Stuart's Top Picks
    Select
    GGG, Greenland, Greenland Minerals, past-pick

  • Lovisa

    LOV
    March 10, 2021
    $14.67
    September 6, 2021
    $19.47
    32.72%

    Date of inclusion: 10 March 2021
    Share price on inclusion: $14.67

    Date of exclusion: 6 September 2021
    Share price on exclusion: $19.47

     

    Following a performance of 32.7% since 10 March 2021, we are removing Lovisa from Marc & Stuart’s Top Picks list.

    Let’s start off by saying that we still like Lovisa as a company. It once again performed strongly in the past six months of the financial year and the shares ticked up nicely after the results announcement in August. However,...

    Save $$$
    Most Popular
    30-Day Free Trial
    $0
    No Credit Card Required!
    Get access to 4 publications
    Weekly Investor Webinar
    Access to Marc & Stuart's Top Picks
    Select
    Most Popular
    Profit Premium
    $69
    Get access to 4 publications
    Access to the full research Archive
    Weekly Investor Webinar
    Access to Marc & Stuart's Top Picks
    Select
    Most Popular
    30-Day Free Trial
    $0
    No Credit Card Required!
    Get access to 4 publications
    Weekly Investor Webinar
    Access to Marc & Stuart's Top Picks
    Select
    Most Popular
    Profit Premium
    $59
    BILLED ANNUALLY
    Get access to 4 publications
    Access to the full research Archive
    Weekly Investor Webinar
    Access to Marc & Stuart's Top Picks
    Select
    LOV, Lovisa, past-pick, watch-list

  • Neuren Pharmaceuticals

    NEU
    March 10, 2021
    $1.255
    August 25, 2021
    $2.24
    78.49%

    Date of inclusion: 10 March 2021
    Share price on inclusion: $1.255

    Date of exclusion: 25 August 2021
    Share price on exclusion: $2.24

     

    Neuren has performed well since we included it in Marc and Stuart’s Top Picks list on 10 March 2021, rising 78.5%. We like the potential of this company to revolutionise the treatment of rare neurological disorders with its trofinenide drug. The Phase 2 data in Rett Ryndrome looked good and the company secured Acadia Pharmaceuticals (Nasdaq: ACAD) ...

    Save $$$
    Most Popular
    30-Day Free Trial
    $0
    No Credit Card Required!
    Get access to 4 publications
    Weekly Investor Webinar
    Access to Marc & Stuart's Top Picks
    Select
    Most Popular
    Profit Premium
    $69
    Get access to 4 publications
    Access to the full research Archive
    Weekly Investor Webinar
    Access to Marc & Stuart's Top Picks
    Select
    Most Popular
    30-Day Free Trial
    $0
    No Credit Card Required!
    Get access to 4 publications
    Weekly Investor Webinar
    Access to Marc & Stuart's Top Picks
    Select
    Most Popular
    Profit Premium
    $59
    BILLED ANNUALLY
    Get access to 4 publications
    Access to the full research Archive
    Weekly Investor Webinar
    Access to Marc & Stuart's Top Picks
    Select
    NEU, past-pick

  • Revasum

    RVS
    March 10, 2021
    $0.35
    October 12, 2021
    $0.75
    114.29%

    Date of inclusion: 10 March 2021
    Share price on inclusion: $0.35

    Date of exclusion: 12 October 2021
    Share price on exclusion: $0.75

     

    After a six-month investment in Revasum we are taking profit on RVS. The stock has rallied very hard recently and we think there is downside from here.

    We still like the company fundamentally, but it’s hard to argue with a return of 120% in six months.

    What is the risk in the near term?

    One of the reasons to invest in RVS is the expected o...

    Save $$$
    Most Popular
    30-Day Free Trial
    $0
    No Credit Card Required!
    Get access to 4 publications
    Weekly Investor Webinar
    Access to Marc & Stuart's Top Picks
    Select
    Most Popular
    Profit Premium
    $69
    Get access to 4 publications
    Access to the full research Archive
    Weekly Investor Webinar
    Access to Marc & Stuart's Top Picks
    Select
    Most Popular
    30-Day Free Trial
    $0
    No Credit Card Required!
    Get access to 4 publications
    Weekly Investor Webinar
    Access to Marc & Stuart's Top Picks
    Select
    Most Popular
    Profit Premium
    $59
    BILLED ANNUALLY
    Get access to 4 publications
    Access to the full research Archive
    Weekly Investor Webinar
    Access to Marc & Stuart's Top Picks
    Select
    past-pick, Revasum, RVS

  • Weebit Nano

    WBT
    March 10, 2021
    $2.04
    March 24, 2021
    $2.61
    27.94%

    Date of inclusion: 10 March 2021
    Share price on inclusion: $2.04

    Date of exclusion: 24 March 2021
    Share price on exclusion: $2.61...

    Save $$$
    Most Popular
    30-Day Free Trial
    $0
    No Credit Card Required!
    Get access to 4 publications
    Weekly Investor Webinar
    Access to Marc & Stuart's Top Picks
    Select
    Most Popular
    Profit Premium
    $69
    Get access to 4 publications
    Access to the full research Archive
    Weekly Investor Webinar
    Access to Marc & Stuart's Top Picks
    Select
    Most Popular
    30-Day Free Trial
    $0
    No Credit Card Required!
    Get access to 4 publications
    Weekly Investor Webinar
    Access to Marc & Stuart's Top Picks
    Select
    Most Popular
    Profit Premium
    $59
    BILLED ANNUALLY
    Get access to 4 publications
    Access to the full research Archive
    Weekly Investor Webinar
    Access to Marc & Stuart's Top Picks
    Select
    past-pick, WBT, Weebit, Weebit Nano

Register or Login

Please register or login to your account to access this content

Join Membership
Save $$$
Most Popular
30-Day Free Trial
$0
No Credit Card Required!
Get access to 4 publications
Weekly Investor Webinar
Access to Marc & Stuart's Top Picks
Select
Most Popular
Profit Premium
$69
Get access to 4 publications
Access to the full research Archive
Weekly Investor Webinar
Access to Marc & Stuart's Top Picks
Select
Most Popular
30-Day Free Trial
$0
No Credit Card Required!
Get access to 4 publications
Weekly Investor Webinar
Access to Marc & Stuart's Top Picks
Select
Most Popular
Profit Premium
$59
BILLED ANNUALLY
Get access to 4 publications
Access to the full research Archive
Weekly Investor Webinar
Access to Marc & Stuart's Top Picks
Select